Glycemic targets for the optimal treatment of GDM

Clin Obstet Gynecol. 2013 Dec;56(4):788-802. doi: 10.1097/GRF.0b013e3182a8e07d.

Abstract

Lowering glucose is of pivotal importance in the treatment of diabetes in pregnancy. A spectrum of different glucose thresholds can be established and used appropriately to prevent each complication. This article outlines the concept of normality and what definition of normality should be used to evaluate the relationship between the level of glycemia and perinatal outcome.

Publication types

  • Review

MeSH terms

  • Biomarkers / blood
  • Blood Glucose / metabolism*
  • Diabetes, Gestational / blood
  • Diabetes, Gestational / drug therapy*
  • Drug Monitoring*
  • Female
  • Fetal Growth Retardation / etiology
  • Fetal Growth Retardation / prevention & control
  • Fetal Macrosomia / etiology
  • Fetal Macrosomia / prevention & control
  • Glycated Hemoglobin / metabolism
  • Humans
  • Hyperglycemia / blood
  • Hyperglycemia / diagnosis*
  • Hyperglycemia / etiology
  • Hypoglycemic Agents / therapeutic use*
  • Pregnancy
  • Pregnancy Outcome

Substances

  • Biomarkers
  • Blood Glucose
  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • hemoglobin A1c protein, human